Conference Reports for NATAP

IAS 2025, 13th IAS Conference on HIV Science Kigali, Rwanda July 13-17 Back

One-Year Implementation Outcomes of Cabotegravir Long-Acting Injectable PrEP in Men Who Have Sex With Men (MSM) & Transgender Men (TGM): Findings From the PILLAR Study       13th IAS Conference on HIV Science; July 13–17, 2025; Kigali, Rwanda   Dima Dandachi,1